Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
第一作者:
D R,Kuritzkes
第一单位:
Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver, CO 80262, USA. daniel.kuritzkes@UCHSC.edu
作者:
医学主题词
成年人(Adult);抗HIV药(Anti-HIV Agents);抗药性, 微生物(Drug Resistance, Microbial);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);HIV感染(HIV Infections);HIV蛋白酶(HIV Protease);HIV蛋白酶抑制药(HIV Protease Inhibitors);HIV逆转录酶(HIV Reverse Transcriptase);HIV-1(HIV-1);人类(Humans);拉米夫定(Lamivudine);男(雄)性(Male);中年人(Middle Aged);分子序列数据(Molecular Sequence Data);突变(Mutation);RNA, 病毒(RNA, Viral);逆转录酶抑制剂(Reverse Transcriptase Inhibitors);利托纳韦(Ritonavir);病毒载量(Viral Load);齐多夫定(Zidovudine)
DOI
10.1086/315244
PMID
10669331
发布时间
2013-11-21
基金项目
AI-25879/AI/NIAID NIH HHS/United States
AI-38855/AI/NIAID NIH HHS/United States
AI-42567/AI/NIAID NIH HHS/United States
- 浏览18
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



